STAT+: Pharmalittle: We’re reading about FDA guidance on AI, meds releasing ‘forever chemicals,’ and more
STAT
JANUARY 7, 2025
As of last October, the agency had received more than 500 drug submissions with AI components going back to 2016, with a large number in the areas of oncology, neurology, and gastroenterology. Most of the compounds came from commonly prescribed medications including antidepressants and statins.
Let's personalize your content